Introduction

In pharmaceutical development and quality control, the terms related compounds and impurities are frequently used when discussing product quality, method validation, stability studies, and regulatory compliance. Although the terms are closely related, they are not interchangeable.

Understanding the distinction between these concepts is important when developing HPLC methods, interpreting chromatographic data, and assessing pharmaceutical product quality.

What Are Related Compounds?

Related compounds are substances that are chemically associated with the active pharmaceutical ingredient (API) and may arise during manufacturing, storage, or degradation.

Related compounds can include:

• Process-related substances
• Synthetic intermediates
• Manufacturing by-products
• Degradation products
• Transformation products
• Chemically related species

These compounds are typically monitored during pharmaceutical development and routine quality testing because they provide information about manufacturing consistency, product stability, and overall quality.

What Are Impurities?

Impurities are unwanted substances present within the drug substance or drug product.

Examples may include:

• Process impurities
• Residual starting materials
• Manufacturing by-products
• Degradation products
• Contaminants

Impurities are generally monitored because they may affect:

• Product quality
• Safety
• Stability
• Regulatory compliance

HPLC is one of the most commonly used analytical techniques for detecting and quantifying impurities.

Relationship Between Related Compounds and Impurities

A simple way to view the relationship is:

All impurities are related compounds, but not all related compounds are impurities.  In other words, impurities are generally considered a subset of the broader category of related compounds.

Related compound methods are often designed to detect and monitor a variety of chemically associated species, while impurity assessments focus specifically on substances that are considered undesirable or require control.

Why Related Compound Testing Is Important

Related compound analysis helps laboratories:

• Monitor product stability
• Evaluate manufacturing consistency
• Identify degradation pathways
• Characterize product quality
• Support regulatory submissions

Related compound profiles can provide valuable information even when certain compounds are not classified as reportable impurities.

Role of HPLC in Related Compound Analysis

HPLC is widely used for:

• Related substances testing
• Impurity profiling
• Stability-indicating methods
• Degradation studies
• Pharmaceutical method validation

These methods are often designed to separate the API from structurally related compounds so that each component can be evaluated independently.

Pharmaceutical Quality Considerations

Regulatory agencies generally require manufacturers to establish appropriate controls for:

• Known impurities
• Unknown impurities
• Related compounds
• Degradation products
• Process-related materials

The specific reporting and qualification requirements depend on the product, dosage form, and applicable regulatory guidance.

Conclusion

In pharmaceutical analysis, related compounds encompass process-related substances, degradation products, and other chemically related species associated with a drug substance or drug product. Impurities are generally considered a subset of related compounds because they represent unwanted materials present in the product. Understanding this distinction helps support effective HPLC method development, impurity profiling, and pharmaceutical quality control.